Cook Medical Tests Aortic Dissection Treatment In STABLE Trial
The 2003 death of Three’s Company actor John Ritter created new awareness of aortic dissection, a condition that affects tens of thousands of Americans each year.
Featured Articles
InterMune Shares Rise On FDA Panel Recommendation
The recommendation caused a 64 percent jump in InterMune stock prices and fueled speculation that the Brisbane, Calif.-based company is ripe for acquisition.
mikehavRx.com News Bytes: $DCTH, $TRA, $POT, $SUPG, $ACCP.OB, $AMLN
Delcath’s Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient’s entire body to the anti-cancer drugs.
BioSante Announces Positive Data on Leukemia Drug
BioSante Pharmaceuticals may be known for its sexual health products such as LibiGel, but the Illinois-based company is also developing a novel immunotherapy vaccine to treat cancer.
Cytokinetics Receives Orphan Drug Status for ALS Treatment
Promising data from a Phase I clinical trial of CK-2017357 was announced in January.
Translating Data Into Better Healthcare
Strategic Medicine (SMI) specializes in patient and disease stratification with the end goals of providing better healthcare and identifying unmet clinical needs.
IMUC: Immunotherapy On Multiple Fronts
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
NeoMatrix: A “Pap Smear for Breast Cancer”
Neomatrix of Irvine, Calif., has developed a fully automated, non-invasive device to assess a patient’s risk of developing breast cancer.
Quantum Immunologics’ Alternative to Chemotherapy
The company’s vaccine technology is based on the universal tumor antigen, which has been expressed in all human cancers studied so far.
MicroTransponder Receives $9.6M Funding for Wireless Pain Treatment
MicroTransponder is developing a wireless neurostimulation device for the treatment of chronic pain.